Program Will Provide Personal Guide to Help Local Cancer Patients Better Navigate Their Cancer Experience Thanks to Support from AstraZeneca
PHILADELPHIA, June 16 /PRNewswire/ -- The American Cancer Society today launched its Patient Navigator Program at the Kimmel Cancer Center at Jefferson in Philadelphia, thanks to support received from AstraZeneca Pharmaceuticals LP. This is the first site to launch in Pennsylvania as part of a strategic nationwide effort to significantly extend the reach of this innovative program and assist individual cancer patients in negotiating the health care system.
"A cancer diagnosis can be a life-changing experience for patients, their families and their caregivers," said Garry Pincock, CEO, American Cancer Society Pennsylvania Division. "Our patient navigator is able to provide support every step of the way, from explaining what to expect with chemotherapy, to making sure patients have transportation to and from appointments. Fighting cancer is a difficult, challenging journey; but with the help of trained American Cancer Society patient navigators, people don't have to go through it alone."
The American Cancer Society Patient Navigator Program directly connects cancer patients to a cancer education and support specialist -- known as a "patient navigator" -- who, through one-on-one relationships, serves as a personal guide to patients and caregivers as they face the psychosocial, emotional and financial challenges that cancer can bring. The service is free and confidential, and places an emphasis on assisting the medically underserved.
AstraZeneca's support will enable the launch of a full-time American Cancer Society Patient Navigator Program at the Kimmel Cancer Center at Jefferson. According to American Cancer Society estimates, over 70 thousand people in Pennsylvania were diagnosed with cancer in 2008. The gift is part of a $10 million pledge by AstraZen
Copyright©2009 PR Newswire.
All rights reserved